Latest Moxidectin Stories
Important guideline revisions made by both parasite-focused organizations address heartworm prevention, treatment and diagnosis; and include information about FDA approval of the first-ever treatment
Zoetis Inc., a former business unit of Pfizer Inc., has announced revisions to the Risk Minimization Action Plan (RiskMAP) for ProHeart® 6 (moxidectin), the sustained-release injectable heartworm
SHAWNEE, Kan. Jan.
- A poem in which the author retracts something said in an earlier poem.